BioHarvest Sciences(IL:BHST)
ILA 537.200.00 (0.00%)
IL:BHST
BioHarvest Sciences financials statements
ILA 537.20
At close:0.00 (0.00%)
BioHarvest Sciences (BHST) Ratios
BioHarvest Sciences Ratios
IL:BHST's free cash flow for Q3 2026 was $-2.91M. For the 2026 fiscal year, IL:BHST's free cash flow was decreased by $-427.75K and operating cash flow was $-2.48M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.97 | 0.55 | 0.34 | 0.38 | 1.94 |
| Quick Ratio | 3.38 | 0.29 | 0.25 | 0.26 | 1.62 |
| Cash Ratio | 3.00 | 0.17 | 0.20 | 0.15 | 1.41 |
| Solvency Ratio | -0.43 | -0.49 | -0.39 | -0.69 | -1.28 |
| Operating Cash Flow Ratio | -0.94 | -0.47 | -0.32 | -0.80 | -2.32 |
| Short-Term Operating Cash Flow Coverage | -48.50 | -1.71 | -0.42 | -1.08 | 0.00 |
| Net Current Asset Value | $ 8.28M | $ -15.81M | $ -20.80M | $ -11.00M | $ -1.69M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.55 | 1.49 | 1.12 | 0.26 |
| Debt-to-Equity Ratio | 0.55 | 10.39 | -1.50 | -1.78 | 0.93 |
| Debt-to-Capital Ratio | 0.36 | 0.91 | 2.98 | 2.28 | 0.48 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.87 | 18.80 | -1.01 | -1.58 | 3.58 |
| Debt Service Coverage Ratio | -2.36 | -1.67 | -0.43 | -0.92 | -10.73 |
| Interest Coverage Ratio | -2.05 | -3.62 | -5.08 | -7.59 | -10.55 |
| Debt to Market Cap | 0.03 | 0.04 | 0.30 | 0.13 | 0.00 |
| Interest Debt Per Share | 0.91 | 0.97 | 1.80 | 0.92 | 0.28 |
| Net Debt to EBITDA | 1.33 | -1.18 | -1.74 | -0.97 | 0.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 59.34% | 55.35% | 44.45% | 22.17% | 31.87% |
| EBIT Margin | -24.16% | -43.57% | -83.66% | -178.92% | -429.21% |
| EBITDA Margin | -19.45% | -38.61% | -77.04% | -165.97% | -410.87% |
| Operating Profit Margin | -16.16% | -27.75% | -78.65% | -193.02% | -403.95% |
| Pretax Profit Margin | -32.05% | -51.23% | -99.15% | -204.37% | -467.51% |
| Net Profit Margin | -32.27% | -51.27% | -99.15% | -204.37% | -467.51% |
| Continuous Operations Profit Margin | -32.27% | -51.27% | -99.15% | -204.37% | -467.51% |
| Net Income Per EBT | 100.69% | 100.06% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 198.37% | 184.65% | 126.07% | 105.88% | 115.73% |
| Return on Assets (ROA) | -23.36% | -51.65% | -83.75% | -119.62% | -96.27% |
| Return on Equity (ROE) | -43.76% | -970.90% | 84.59% | 189.51% | -344.20% |
| Return on Capital Employed (ROCE) | -13.94% | -65.06% | 86.93% | 499.15% | -116.55% |
| Return on Invested Capital (ROIC) | -13.42% | -45.32% | -105.46% | -156.94% | -110.69% |
| Return on Tangible Assets | -23.36% | -51.65% | -83.75% | -119.62% | -96.27% |
| Earnings Yield | -11.65% | -12.90% | -18.57% | -17.22% | -15.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.38 | 18.77 | 13.09 | 7.61 | 3.39 |
| Payables Turnover | 5.34 | 3.19 | 3.96 | 4.01 | 1.64 |
| Inventory Turnover | 3.08 | 3.08 | 2.85 | 3.11 | 1.54 |
| Fixed Asset Turnover | 2.06 | 1.50 | 2.20 | 1.12 | 0.48 |
| Asset Turnover | 0.72 | 1.01 | 0.84 | 0.59 | 0.21 |
| Working Capital Turnover Ratio | 4.20 | -2.12 | -1.03 | -2.47 | 1.36 |
| Cash Conversion Cycle | 73.98 | 23.67 | 63.56 | 74.46 | 121.17 |
| Days of Sales Outstanding | 23.72 | 19.45 | 27.88 | 47.93 | 107.66 |
| Days of Inventory Outstanding | 118.59 | 118.63 | 127.87 | 117.54 | 236.54 |
| Days of Payables Outstanding | 68.33 | 114.41 | 92.20 | 91.02 | 223.03 |
| Operating Cycle | 142.31 | 138.07 | 155.75 | 165.48 | 344.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.39 | -0.41 | -0.63 | -0.71 | -0.55 |
| Free Cash Flow Per Share | -0.52 | -0.59 | -0.74 | -0.80 | -0.68 |
| Dividend Paid and CapEx Coverage Ratio | -3.07 | -2.36 | -5.78 | -7.36 | -4.14 |
| Capital Expenditure Coverage Ratio | -3.07 | -2.36 | -5.78 | -7.36 | -4.14 |
| Operating Cash Flow Coverage Ratio | -0.51 | -0.48 | -0.38 | -0.88 | -2.56 |
| Operating Cash Flow to Sales Ratio | -0.21 | -0.27 | -0.67 | -1.68 | -3.23 |
| Free Cash Flow Yield | -10.03% | -9.51% | -14.77% | -16.08% | -13.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.65 | -7.75 | -5.39 | -5.81 | -6.33 |
| Price-to-Sales (P/S) Ratio | 2.77 | 3.97 | 5.34 | 11.87 | 29.61 |
| Price-to-Book (P/B) Ratio | 3.75 | 75.25 | -4.56 | -11.01 | 21.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.97 | -10.51 | -6.77 | -6.22 | -7.38 |
| Price-to-Operating Cash Flow Ratio | -13.22 | -14.97 | -7.94 | -7.06 | -9.16 |
| Price-to-Earnings Growth (PEG) Ratio | 0.35 | 0.55 | -0.16 | 0.00 | 0.00 |
| Enterprise Value Multiple | -12.91 | -11.47 | -8.67 | -8.12 | -7.04 |
| Enterprise Value | 86.63M | 111.51M | 84.65M | 74.09M | 60.78M |
| EV to EBITDA | -12.91 | -11.47 | -8.67 | -8.12 | -7.04 |
| EV to Sales | 2.51 | 4.43 | 6.68 | 13.48 | 28.92 |
| EV to Free Cash Flow | -9.04 | -11.71 | -8.47 | -7.06 | -7.21 |
| EV to Operating Cash Flow | -11.99 | -16.68 | -9.93 | -8.02 | -8.95 |
| Tangible Book Value Per Share | 1.38 | 0.08 | -1.10 | -0.45 | 0.23 |
| Shareholders’ Equity Per Share | 1.38 | 0.08 | -1.10 | -0.45 | 0.23 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.87 | 1.56 | 0.94 | 0.42 | 0.17 |
| Net Income Per Share | -0.60 | -0.80 | -0.93 | -0.86 | -0.79 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.33 | 1.18 | 1.19 | 1.14 | 1.09 |
| Research & Development to Revenue | 0.15 | 0.19 | 0.27 | 0.42 | 1.96 |
| SG&A to Revenue | 0.55 | 0.58 | 0.45 | 0.92 | 0.86 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.04 | 0.25 | 1.60 |
| Income Quality | 0.65 | 0.52 | 0.68 | 0.82 | 0.69 |
Currency in USD

